Wakamoto Pharmaceutical Co.,Ltd. (4512.T)
JPY 332.0
(-0.9%)
JPY 332.0
(-0.9%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -3.56 Billion JPY | 4.74% |
| 2022 | -3.74 Billion JPY | -20.59% |
| 2021 | -3.1 Billion JPY | -16.1% |
| 2020 | -2.67 Billion JPY | 1.68% |
| 2019 | -2.71 Billion JPY | 11.56% |
| 2018 | -3.07 Billion JPY | 12.45% |
| 2017 | -3.51 Billion JPY | -22.77% |
| 2016 | -2.85 Billion JPY | -102.46% |
| 2015 | -1.41 Billion JPY | -16.37% |
| 2014 | -1.21 Billion JPY | 15.0% |
| 2013 | -1.42 Billion JPY | -112.3% |
| 2012 | -672.56 Million JPY | -447.67% |
| 2011 | 193.45 Million JPY | -22.15% |
| 2010 | 248.5 Million JPY | 131.17% |
| 2009 | 107.49 Million JPY | 108.79% |
| 2008 | -1.22 Billion JPY | 52.2% |
| 2007 | -2.55 Billion JPY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -3.79 Billion JPY | -6.35% |
| 2023 Q3 | -3.46 Billion JPY | 10.39% |
| 2023 Q4 | -3.56 Billion JPY | -2.99% |
| 2023 Q1 | -4.08 Billion JPY | -9.17% |
| 2023 FY | -3.56 Billion JPY | 4.74% |
| 2023 Q2 | -3.86 Billion JPY | 5.45% |
| 2022 Q1 | -3.33 Billion JPY | -7.54% |
| 2022 FY | -3.74 Billion JPY | -20.59% |
| 2022 Q4 | -3.74 Billion JPY | -4.54% |
| 2022 Q3 | -3.57 Billion JPY | -1.25% |
| 2022 Q2 | -3.53 Billion JPY | -5.94% |
| 2021 Q2 | -3.19 Billion JPY | -11.72% |
| 2021 Q4 | -3.1 Billion JPY | -10.18% |
| 2021 Q3 | -2.81 Billion JPY | 11.93% |
| 2021 FY | -3.1 Billion JPY | -16.1% |
| 2021 Q1 | -2.86 Billion JPY | -7.09% |
| 2020 Q4 | -2.67 Billion JPY | -12.98% |
| 2020 Q1 | -3.09 Billion JPY | -13.92% |
| 2020 Q2 | -2.71 Billion JPY | 12.4% |
| 2020 Q3 | -2.36 Billion JPY | 12.8% |
| 2020 FY | -2.67 Billion JPY | 1.68% |
| 2019 Q4 | -2.71 Billion JPY | -13.5% |
| 2019 FY | -2.71 Billion JPY | 11.56% |
| 2019 Q3 | -2.39 Billion JPY | 6.42% |
| 2019 Q2 | -2.55 Billion JPY | 8.97% |
| 2019 Q1 | -2.81 Billion JPY | 8.52% |
| 2018 Q3 | -3.28 Billion JPY | 7.27% |
| 2018 FY | -3.07 Billion JPY | 12.45% |
| 2018 Q4 | -3.07 Billion JPY | 6.35% |
| 2018 Q2 | -3.53 Billion JPY | 0.71% |
| 2018 Q1 | -3.56 Billion JPY | -1.53% |
| 2017 Q4 | -3.51 Billion JPY | -13.47% |
| 2017 FY | -3.51 Billion JPY | -22.77% |
| 2017 Q3 | -3.09 Billion JPY | -2.53% |
| 2017 Q2 | -3.01 Billion JPY | 5.41% |
| 2017 Q1 | -3.19 Billion JPY | -11.57% |
| 2016 Q1 | -1.73 Billion JPY | -22.72% |
| 2016 FY | -2.85 Billion JPY | -102.46% |
| 2016 Q4 | -2.85 Billion JPY | -21.94% |
| 2016 Q3 | -2.34 Billion JPY | 5.24% |
| 2016 Q2 | -2.47 Billion JPY | -42.78% |
| 2015 Q2 | -1.45 Billion JPY | -7.59% |
| 2015 FY | -1.41 Billion JPY | -16.37% |
| 2015 Q4 | -1.41 Billion JPY | 11.96% |
| 2015 Q1 | -1.35 Billion JPY | -11.71% |
| 2015 Q3 | -1.6 Billion JPY | -9.97% |
| 2014 FY | -1.21 Billion JPY | 15.0% |
| 2014 Q2 | -1.57 Billion JPY | 13.91% |
| 2014 Q4 | -1.21 Billion JPY | 16.09% |
| 2014 Q3 | -1.44 Billion JPY | 8.3% |
| 2014 Q1 | -1.83 Billion JPY | -28.31% |
| 2013 Q2 | -1.23 Billion JPY | 3.03% |
| 2013 Q3 | -1.46 Billion JPY | -18.07% |
| 2013 Q4 | -1.42 Billion JPY | 2.42% |
| 2013 FY | -1.42 Billion JPY | -112.3% |
| 2013 Q1 | -1.27 Billion JPY | -90.03% |
| 2012 Q3 | -474.7 Million JPY | -191.91% |
| 2012 Q4 | -672.56 Million JPY | -41.68% |
| 2012 Q2 | -162.62 Million JPY | -8.2% |
| 2012 FY | -672.56 Million JPY | -447.67% |
| 2012 Q1 | -150.3 Million JPY | -177.7% |
| 2011 Q2 | 579.79 Million JPY | 2.51% |
| 2011 FY | 193.45 Million JPY | -22.15% |
| 2011 Q3 | 563.59 Million JPY | -2.79% |
| 2011 Q1 | 565.56 Million JPY | 127.59% |
| 2011 Q4 | 193.45 Million JPY | -65.68% |
| 2010 Q4 | 248.5 Million JPY | -29.94% |
| 2010 FY | 248.5 Million JPY | 131.17% |
| 2010 Q1 | 42.25 Million JPY | -60.69% |
| 2010 Q2 | 35.33 Million JPY | -16.39% |
| 2010 Q3 | 354.67 Million JPY | 903.9% |
| 2009 Q4 | 107.49 Million JPY | -71.77% |
| 2009 Q3 | 380.78 Million JPY | 199.84% |
| 2009 Q2 | -381.38 Million JPY | 0.0% |
| 2009 FY | 107.49 Million JPY | 108.79% |
| 2008 Q3 | -1.28 Billion JPY | 0.0% |
| 2008 Q4 | -1.22 Billion JPY | 4.94% |
| 2008 FY | -1.22 Billion JPY | 52.2% |
| 2007 FY | -2.55 Billion JPY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 1.22 Billion JPY | 390.948% |
| Takeda Pharmaceutical Company Limited | 4385.95 Billion JPY | 100.081% |
| Sumitomo Pharma Co., Ltd. | 389.83 Billion JPY | 100.914% |
| Shionogi & Co., Ltd. | -346.47 Billion JPY | 98.971% |
| Nippon Shinyaku Co., Ltd. | -42.15 Billion JPY | 91.545% |
| Kaken Pharmaceutical Co., Ltd. | -61.47 Billion JPY | 94.202% |
| Eisai Co., Ltd. | -97.93 Billion JPY | 96.361% |
| Morishita Jintan Co., Ltd. | -667 Million JPY | -434.351% |
| Hisamitsu Pharmaceutical Co., Inc. | -51.82 Billion JPY | 93.122% |
| Mochida Pharmaceutical Co., Ltd. | -32.92 Billion JPY | 89.174% |
| Fuso Pharmaceutical Industries,Ltd. | 7.6 Billion JPY | 146.884% |
| Nippon Chemiphar Co., Ltd. | 7.78 Billion JPY | 145.805% |
| Tsumura & Co. | 1.61 Billion JPY | 320.688% |
| Kissei Pharmaceutical Co., Ltd. | -44.16 Billion JPY | 91.929% |
| Torii Pharmaceutical Co., Ltd. | -34.43 Billion JPY | 89.65% |
| Towa Pharmaceutical Co., Ltd. | 172.7 Billion JPY | 102.064% |
| Fuji Pharma Co., Ltd. | 26.62 Billion JPY | 113.387% |
| Zeria Pharmaceutical Co., Ltd. | 28.98 Billion JPY | 112.298% |
| KYORIN Holdings, Inc. | 7.06 Billion JPY | 150.483% |
| Taiko Pharmaceutical Co.,Ltd. | 704 Million JPY | 606.267% |
| Daito Pharmaceutical Co.,Ltd. | 5.99 Billion JPY | 159.481% |
| SymBio Pharmaceuticals Limited | -6.51 Billion JPY | 45.311% |
| MedRx Co., Ltd | -1.72 Billion JPY | -107.216% |
| Mizuho Medy Co.,Ltd. | -8.71 Billion JPY | 59.111% |
| Solasia Pharma K.K. | -668 Million JPY | -433.551% |
| Modalis Therapeutics Corporation | -1.47 Billion JPY | -142.303% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | -7.25 Billion JPY | 50.86% |
| Sawai Group Holdings Co., Ltd. | 56.52 Billion JPY | 106.306% |
| Cyfuse Biomedical K.K. | -2.96 Billion JPY | -20.378% |
| Toho Holdings Co., Ltd. | -98.42 Billion JPY | 96.379% |
| Koa Shoji Holdings Co.,Ltd. | -11.12 Billion JPY | 67.976% |